7
Participants
Start Date
February 27, 2020
Primary Completion Date
September 8, 2023
Study Completion Date
September 8, 2023
CD8+ Memory T Cell Infusion
Allogeneic phenotypic CD8+ memory T cells from HLA matched donors infused at the time of hematopoietic cell transplantation
Thiotepa
5 mg/kg/day: IV for 2 consecutive days (days -6 to -5)
Fludarabine
25 mg/m2/day: IV for 5 consecutive days (days -6 to -2)
Hyperfractionated TBI
Administered in 11 fractions of 125 cGy over 4 days (Total dose of 1375 cGy)
Busulfan
6 mg/kg/dose Q24h IV. Infused over 3 hours. 1 dose per day x 4 consecutive days x 3.6 mg/kg/dose = 14.4 mg/kg
Cyclophosphamide
60 mg/kg/dose Q24h IV. Infused over 2 hours. 1 dose per day x 2 consecutive days x 60 mg/kg/dose = 120 mg/kg
Stanford Medical Center, Stanford
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
Robert Lowsky
OTHER